Skip to main content
. 2001 Sep 1;108(5):679–688. doi: 10.1172/JCI12976

Figure 8.

Figure 8

Survival of CX3CR1–/– and CX3CR1+/+ recipient mice after cardiac transplantation. CX3CR1–/– mice rejected fully MHC-disparate cardiac allografts at the same tempo as CX3CR1+/+ recipients. However, whereas administration of a subtherapeutic dose of CsA prolonged allograft survival only 2–3 days in CX3CR1+/+ recipients, allograft survival was significantly prolonged in CX3CR1–/– mice treated with the same course of CsA (P < 0.005 Mann-Whitney vs. wild-type/CsA, n = 6/group).